Literature DB >> 16267263

Gamma-glutamyl carboxylase (GGCX) microsatellite and warfarin dosing.

Leslie Y Chen, Niclas Eriksson, Rhian Gwilliam, David Bentley, Panos Deloukas, Mia Wadelius.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16267263     DOI： 10.1182/blood-2005-04-1711

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  18 in total

1.  Genetic mutation of vitamin K-dependent gamma-glutamyl carboxylase domain in patients with calcium oxalate urolithiasis.

Authors:  Jiankun Qiao; Tao Wang; Jun Yang; Jihong Liu; Xiaoxin Gong; Xiaolin Guo; Shaogang Wang; Zhangqun Ye
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-10-11

Review 2.  Pharmacogenetics of warfarin: challenges and opportunities.

Authors:  Ming Ta Michael Lee; Teri E Klein
Journal:  J Hum Genet       Date:  2013-05-09       Impact factor: 3.172

Review 3.  The future of warfarin pharmacogenetics in under-represented minority groups.

Authors:  Larisa H Cavallari; Minoli A Perera
Journal:  Future Cardiol       Date:  2012-07

4.  Dosage individualization of warfarin using artificial neural networks.

Authors:  Mohammad I Saleh; Sameh Alzubiedi
Journal:  Mol Diagn Ther       Date:  2014-06       Impact factor: 4.074

5.  Association of the GGCX (CAA)16/17 repeat polymorphism with higher warfarin dose requirements in African Americans.

Authors:  Larisa H Cavallari; Minoli Perera; Mia Wadelius; Panos Deloukas; Gelson Taube; Shitalben R Patel; Keston Aquino-Michaels; Marlos A G Viana; Nancy L Shapiro; Edith A Nutescu
Journal:  Pharmacogenet Genomics       Date:  2012-02       Impact factor: 2.089

6.  Evaluation of genetic factors for warfarin dose prediction.

Authors:  Michael D Caldwell; Richard L Berg; Kai Qi Zhang; Ingrid Glurich; John R Schmelzer; Steven H Yale; Humberto J Vidaillet; James K Burmester
Journal:  Clin Med Res       Date:  2007-03

7.  Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients.

Authors:  Liyan Miao; Jian Yang; Chenrong Huang; Zhenya Shen
Journal:  Eur J Clin Pharmacol       Date:  2007-09-27       Impact factor: 2.953

Review 8.  Warfarin Pharmacogenetics: New Life for an Old Drug.

Authors:  Ming-Shien Wen; Ming Ta Michael Lee
Journal:  Acta Cardiol Sin       Date:  2013-05       Impact factor: 2.672

9.  The largest prospective warfarin-treated cohort supports genetic forecasting.

Authors:  Mia Wadelius; Leslie Y Chen; Jonatan D Lindh; Niclas Eriksson; Mohammed J R Ghori; Suzannah Bumpstead; Lennart Holm; Ralph McGinnis; Anders Rane; Panos Deloukas
Journal:  Blood       Date:  2008-06-23       Impact factor: 22.113

10.  High-resolution SNP and haplotype maps of the human gamma-glutamyl carboxylase gene (GGCX) and association study between polymorphisms in GGCX and the warfarin maintenance dose requirement of the Japanese population.

Authors:  Pei-Chieng Cha; Taisei Mushiroda; Atsushi Takahashi; Shigeru Saito; Hideki Shimomura; Takao Suzuki; Naoyuki Kamatani; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2007-09-05       Impact factor: 3.172
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.